OraVerse

DRUG3 trials

Sponsors

Novocol Pharmaceutical of Canada, Inc., Dalhousie University, Cairo University

Conditions

Anesthesia, LocalAnesthesia, ReversalDental AnesthesiaSoft Tissue Injuries

Phase 3

Effectiveness of Phentolamine Mesylate as a Reversing Agent for Local Anesthesia in Children

RecruitingNCT05448807

Cairo UniversitySoft Tissue Injuries

Start: 2025-07-05End: 2026-06-30Target: 100Updated: 2025-07-10

Phase 4

Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients

CompletedNCT01474382

Novocol Pharmaceutical of Canada, Inc.Anesthesia, Local, Anesthesia, Reversal, Dental Anesthesia

Start: 2012-02-29End: 2014-08-31Updated: 2014-08-29

Reversing the Effects of 0.5% Bupivacaine

CompletedNCT02995291

Dalhousie UniversityAnesthesia, Local

Start: 2017-02-10End: 2019-09-15Updated: 2020-01-29